Skip to main content
. 2023 Oct 11;5(1):vdad116. doi: 10.1093/noajnl/vdad116

Table 3.

Cox proportional hazards model for overall survival

Variable
(Bolded value has unfavorable outcome)
P-value Hazard Ratio (95% CI)
Assigned treatment (Placebo vs. Cediranib) 0.648 0.91 (0.62, 1.34)
MGMT (Methylated vs. Unmethylated)  < 0.001 2.11 (1.40, 3.17)
RPA (RPA III vs. IV) 0.014 2.22 (1.18, 4.20)
RPA (RPA III vs. V)  < 0.001 5.72 (2.74, 11.97)